Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 2529 entries
View as:

Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Phase: N/A Priority: Normal
NCT ID: NCT01350115 Org: User:
Start: 04/30/11 End: 10/31/12 Due: 10/31/13

Pharmacokinetics of AGO178 in Participants With Liver Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01531309 Org: User:
Start: 02/08/11 End: 09/02/11 Due: 09/02/12

Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab)

Phase: N/A Priority: Normal
NCT ID: NCT05320159 Org: User:
Start: 02/03/21 End: 03/31/21 Due: 03/31/22

ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

Phase: N/A Priority: Normal
NCT ID: NCT00490139 Org: User:
Start: 05/16/07 End: 07/01/21 Due: 07/01/22

Sickle Cell Disease: A Retrospective Chart Review

Phase: N/A Priority: Normal
NCT ID: NCT01441375 Org: User:
Start: 07/31/11 End: 07/31/12 Due: 07/31/13

EPO906 Therapy in Patients With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00035165 Org: User:
Start: 03/31/02 End: - Due: -

Trial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase.

Phase: N/A Priority: Normal
NCT ID: NCT01605981 Org: User:
Start: 02/28/14 End: 01/31/17 Due: 01/31/18

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC

Phase: N/A Priority: Normal
NCT ID: NCT02941926 Org: User:
Start: 11/30/16 End: 11/09/22 Due: 11/09/23

Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)

Phase: N/A Priority: Normal
NCT ID: NCT04868968 Org: User:
Start: 09/20/21 End: 05/05/23 Due: 05/05/24

Regulatory Post-Marketing Surveillance Study for Brolucizumab

Phase: N/A Priority: Normal
NCT ID: NCT04985487 Org: User:
Start: 08/18/21 End: 06/14/26 Due: 06/14/27

Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT02370706 Org: User:
Start: 05/21/15 End: 11/09/20 Due: 11/09/21

Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01338831 Org: User:
Start: 09/30/11 End: 03/31/14 Due: 03/31/15

First-in-human Study to Assess the Safety and Pharmacokinetics of LML134 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02334449 Org: User:
Start: 02/28/15 End: 02/29/16 Due: 02/28/17

Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00784212 Org: User:
Start: 10/31/08 End: 09/30/10 Due: 09/30/11

Dabrafenib and/or Trametinib Rollover Study

Phase: N/A Priority: Normal
NCT ID: NCT03340506 Org: User:
Start: 12/28/17 End: 12/21/27 Due: 12/21/28

Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00439647 Org: User:
Start: 12/31/06 End: 10/31/10 Due: 10/31/11

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT01064791 Org: User:
Start: 12/31/09 End: 08/31/12 Due: 08/31/13

Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

Phase: N/A Priority: Normal
NCT ID: NCT01394029 Org: User:
Start: 07/31/11 End: 10/31/15 Due: 10/31/16

BKM120 as Second-line Therapy for Advanced Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01289041 Org: User:
Start: 02/28/11 End: 03/31/14 Due: 03/31/15

3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs

Phase: N/A Priority: Normal
NCT ID: NCT00718861 Org: User:
Start: 05/31/08 End: 04/30/13 Due: 04/30/14

Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin

Phase: N/A Priority: Normal
NCT ID: NCT01871558 Org: User:
Start: 06/30/13 End: 02/28/15 Due: 02/28/16

Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT01520922 Org: User:
Start: 03/31/12 End: 11/30/15 Due: 11/30/16

A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT01315275 Org: User:
Start: 02/28/11 End: 08/31/12 Due: 08/31/13

Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria

Phase: N/A Priority: Normal
NCT ID: NCT01228344 Org: User:
Start: 05/01/10 End: 09/30/15 Due: 09/30/16

Patient Characteristics, Associated Factors, and Clinical Outcomes of Prescribing Encorafenib and Binimetenib Versus Dabrafenib and Trametinib Among BRAF v600 Mutated Metastatic Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT05806268 Org: User:
Start: 07/30/21 End: 03/28/22 Due: 03/28/23